Atara Biotherapeutics Announces First Quarter 2020 Financial Results and Operational Progress

Go back to Atara Biotherapeutics Announces First Quarter 2020 Financial Results and Operational Progress

ATARA Biotherapeutics (ATRA) Tops Q1 EPS by 21c

May 6, 2020 5:42 PM EDT

ATARA Biotherapeutics (NASDAQ: ATRA) reported Q1 EPS of ($1.20), $0.21 better than the analyst estimate of ($1.41).

Atara believes that its cash, cash equivalents and short-term investments as of March 31, 2020, are sufficient to fund planned operations into the second quarter of 2021.

Cash, cash equivalents and short-term... More